{"SPADE_UN_14337": {"basic": {"SPADE ID": "SPADE_UN_14337", "Peptide Name": "LP-65", "Sequence": "IEELLKKAEEQQKKNEEELKKLEX", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.30089693]HIV-1 HXB2:inhibition of cell-cell fusion in TZM-bl cells(IC50=14±3 pM);HIV-1 NL4-3:inhibition of pseudovirus infection in TZM-bl cells(IC50=8±3 pM);HIV-1 JRCSF:inhibition of virus infection in TZM-bl cells(IC50=7±2 pM);T-20 sensitive HIV-1(NL4-3D36G):inhibition of virus infection in TZM-bl cells(IC50<0.01 nM);T-20 resistant HIV-1 NL4-3(WT,I37T,V38A,V38 M,Q40H,N43K,G36S/V38 M,I37T/N43K,V38A/N42T):inhibition of virus infection in TZM-bl cells(IC50=0.15-88.63 nM);HIV-2(ROD,ST):inhibition of virus infection in TZM-bl cells(IC50=0.23-0.75 nM);SIV(239,PBJ):inhibition of virus infection in TZM-bl cells(IC50=0.07-0.04 nM);HIV-1(3 A, 13 B, 7 C, 1 G, 1 A/C, 5 A/E, 6 B/C pseudovirus subtypes):inhibition of pseudovirus infection in TZM-bl cells(IC50=35 pM).", "Linear/Cyclic": "Linear", "Sequence Length": 24}, "extended_data_url": "SPADE_UN_14337_extended.json"}}